{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:22:16Z","timestamp":1787772136810,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      The coinfection of\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      and SARS-CoV-2 is called tuberculosis and COVID-19 coinfection (TB\u2013COVID-19). We aimed to share the clinical, radiological, and laboratory findings and treatment processes of our patients with TB\u2013COVID-19 coinfection in our tertiary reference hospital.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients aged 18 years and over and hospitalized in the tuberculosis service between March 2020 and September 2022 were included. All coinfected patients whose COVID-19 polymerase chain reaction results were positive while receiving tuberculosis treatment or who were diagnosed with tuberculosis while receiving treatment for COVID-19 were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The number of patients was 39; 61.6% of males; the mean age was 52 \u00b1 17.1 years; 20% were foreign nationals; 92.5% were Asian; 69.5% had a bacteriological diagnosis; 84.6% had pulmonary tuberculosis; 10% had received antituberculosis treatment before; and 87.5% were sensitive to the first-line antituberculosis drugs. The most common comorbidities were diabetes and hypertension. 87.5% of the patients were diagnosed with tuberculosis and were superinfected with COVID-19 while receiving tuberculosis treatment. 49.5% of patients had received at least one dose of COVID-19 vaccine. The most common presenting symptom was cough and sputum; the prominent laboratory parameter was C-reactive protein increase, and thorax computed tomography finding was consolidation, tree-in-bud, and cavitation. While 45.9% of the patients were still under treatment, 1 (2.5%) patient also resulted in mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In this study, attention was drawn to two infectious diseases seen with respiratory tract symptoms. The mortality rate was found to be low. Neither disease was found to be a factor aggravating the course of each other.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmy.ijmy_189_23","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T20:00:37Z","timestamp":1710878437000},"page":"28-33","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Two Difficult Pandemics: Tuberculosis and COVID-19"],"prefix":"10.4103","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6858-6824","authenticated-orcid":false,"given":"Zeynep Yegin","family":"Katran","sequence":"first","affiliation":[{"name":"Department of Allergy and Immunology, S\u00fcreyyapa\u015fa Training and Research Hospital, University of Health Sciences, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Babal\u0131k","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, S\u00fcreyyapa\u015fa Training and Research Hospital, University of Health Sciences, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayla","family":"T\u00fcrkar","sequence":"additional","affiliation":[{"name":"Department of Radiology, S\u00fcreyyapa\u015fa Training and Research Hospital, University of Health Sciences, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma K\u00fcbra","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, S\u00fcreyyapa\u015fa Training and Research Hospital, University of Health Sciences, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bet\u00fcl","family":"\u00c7akmak","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, S\u00fcreyyapa\u015fa Training and Research Hospital, University of Health Sciences, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"key":"R1-20240902","doi-asserted-by":"crossref","first-page":"210264","DOI":"10.1183\/16000617.0264-2021","article-title":"COVID-19 and tuberculosis:The double whammy of respiratory pathogens","volume":"31","author":"Shariq","year":"2022","journal-title":"Eur Respir Rev"},{"key":"R2-20240902","doi-asserted-by":"crossref","first-page":"2102538","DOI":"10.1183\/13993003.02538-2021","article-title":"Tuberculosis and COVID-19 co-infection: description of the global cohort","volume":"59","year":"2022","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"R4-20240902","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.ijid.2022.03.011","article-title":"The WHO global tuberculosis 2021 report \u2013Not so good news and turning the tide back to End TB","volume":"124","author":"Chakaya","year":"2022","journal-title":"Int J Infect Dis"},{"key":"R5-20240902","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.dsx.2020.07.034","article-title":"Tuberculosis in the era of COVID-19 in India","volume":"14","author":"Jain","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"R6-20240902","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pulmoe.2020.12.012","article-title":"Tuberculosis and COVID-19 interaction:A review of biological, clinical and public health effects","volume":"27","author":"Visca","year":"2021","journal-title":"Pulmonology"},{"key":"R7-20240902","doi-asserted-by":"crossref","first-page":"e059396","DOI":"10.1136\/bmjopen-2021-059396","article-title":"Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection:A systematic review and meta-analysis (from November 2019 to March 2021)","volume":"12","author":"Wang","year":"2022","journal-title":"BMJ Open"},{"key":"R8-20240902","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4103\/ijmy.ijmy_81_22","article-title":"Scientometric analysis of the world scientific production on tuberculosis associated with COVID-19","volume":"11","author":"Nieto-Chumbipuma","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"R9-20240902","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/S2214-109X(14)70361-4","article-title":"Baroness Masham of Ilton, Oxley A, Oliver M. The WHO 2014 global tuberculosis report- -further to go","volume":"3","author":"Zumla","year":"2015","journal-title":"Lancet Glob Health"},{"key":"R10-20240902","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4103\/ijmy.ijmy_167_22","article-title":"Effect of COVID-19 pandemic on incidence of mycobacterial diseases among suspected tuberculosis pulmonary patients in Tehran, Iran","volume":"11","author":"Aghajani","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"R11-20240902","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1183\/13993003.01708-2020","article-title":"Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital","volume":"56","author":"Stochino","year":"2020","journal-title":"Eur Respir J"},{"key":"R12-20240902","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4103\/ijmy.ijmy_90_22","article-title":"COVID-19 coinfection with Mycobacterium abscessus:A note","volume":"11","author":"Sookaromdee","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"R13-20240902","doi-asserted-by":"crossref","first-page":"657006","DOI":"10.3389\/fmed.2021.657006","article-title":"COVID-19 and tuberculosis coinfection:An overview of case reports\/case series and meta-analysis","volume":"8","author":"Song","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R14-20240902","doi-asserted-by":"crossref","first-page":"740593","DOI":"10.3389\/fmed.2021.740593","article-title":"Clinical characteristics, diagnosis, treatment, and mortality rate of TB\/COVID-19 coinfectetd patients:A systematic review","volume":"8","author":"Koupaei","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R15-20240902","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.2147\/IDR.S370837","article-title":"Clinical features and treatment outcome of coronavirus and tuberculosis co-\u0131nfected patients:A systematic review of case reports","volume":"15","author":"Mollalign","year":"2022","journal-title":"Infect Drug Resist"},{"key":"R17-20240902","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40560-020-00453-4","article-title":"Lymphopenia in severe coronavirus disease-2019 (COVID-19):Systematic review and meta-analysis","volume":"8","author":"Huang","year":"2020","journal-title":"J Intensive Care"},{"key":"R18-20240902","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/ijmy.ijmy_51_21","article-title":"COVID-19 pneumonia with pulmonary tuberculosis:Double trouble","volume":"10","author":"Patil","year":"2021","journal-title":"Int J Mycobacteriol"},{"key":"R19-20240902","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/TCRM.S301817","article-title":"Chloroquine and hydroxychloroquine for the prevention and treatment of COVID-19:A fiction, hope or hype? An updated review","volume":"17","author":"Saghir","year":"2021","journal-title":"Ther Clin Risk Manag"},{"key":"R20-20240902","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijid.2020.09.1464","article-title":"A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates","volume":"101","author":"Meyerowitz-Katz","year":"2020","journal-title":"Int J Infect Dis"},{"key":"R21-20240902","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/jmv.26740","article-title":"Impact of COVID-19 in patients with concurrent co-infections:A systematic review and meta-analyses","volume":"93","author":"Sarkar","year":"2021","journal-title":"J Med Virol"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_189_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:30:08Z","timestamp":1787769008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_189_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_189_23","relation":{},"ISSN":["2212-5531","2212-554X"],"issn-type":[{"value":"2212-5531","type":"print"},{"value":"2212-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-12-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}